Statistics

Total Visits

Views
FOLFOXIRI plus bevacizumab versus FOLFOX plus bevacizumab for patients with metastatic colorectal cancer and ?3 circulating tumour cells: the randomised phase III VISNÚ-1 trial50

File Visits

Downloads
35923-233.pdf20

Select a period of time:

Number of views in the range

Views
FOLFOXIRI plus bevacizumab versus FOLFOX plus bevacizumab for patients with metastatic colorectal cancer and ?3 circulating tumour cells: the randomised phase III VISNÚ-1 trial18

Number of downloads in the range

Downloads
35923-233.pdf5

Views

Views
October 20240
November 20240
December 20241
January 20251
February 20250
March 202516
April 20250
Download CSV file
 untranslated
 untranslated

Number of downloads in the period of time

  • Downloads
  • October 2024
    0
  • November 2024
    0
  • December 2024
    0
  • January 2025
    3
  • February 2025
    2
  • March 2025
    0
  • April 2025
    0
  • Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore16
Germany1
Spain1
 

Top countries by downloads

Downloads
 

Top cities views

Views
Nuremberg1
 

Top cities by downloads

Downloads